SCIEX announces commercial availability of the OneOmics™ Suite

Set in a cloud-based environment, the OneOmics™ Suite enables analysis of complex multi-omics data sets and global collaboration

Framingham, MA — SCIEX a global leader in life science analytical technologies, announced the commercial availability of its OneOmics™ Suite. The platform allows users to streamline the analysis of complex multi-omics data sets, with the speed and scale users have come to expect from cloud-based computing, and collaborate at any time, from any place.

The OneOmics™ Suite of applications enables users to precisely quantify, process, visualize and interpret mass spectrometric proteomics and metabolomics data with transcriptomics data within a single environment. Key features include:

• SWATH^® Acquisition data processing for label-free quantification of proteins and metabolites.
• iTRAQ^® reagents for multiplexed quantification of proteins from complex mixtures.
• ProteinPilot™ app in the cloud for large scale protein identification and library generation experiments
• Apps within the suite cover a multitude of approaches for biomarker discovery and understanding phenotypes, as well as perturbations to biological systems via enriched biological pathways and ontologies.
• A simple, single subscription license that allows multiple users from the same lab to access the same fast, secure environment, and process data at the same time.

“The scalability that the OneOmics™ Suite offers in a cloud-based environment means that our customers are able to analyze big data in a way that accelerates research and collaboration,” said Dom Gostick, Vice President and General Manager, LC-MS Business, at SCIEX. “We have already seen exciting results from our users, such as the Biological Mass Spectrometry & Clinical Proteomics group in the John van Geest Cancer Research Center at Nottingham Trent University, who is investigating the genetic basis of disease and developing new methods of diagnosis and treatment for certain cancers.”

Dr. Dave Boocock, Senior Research Fellow and Group Leader of the Biological Mass Spectrometry & Clinical Proteomics group in the John van Geest Cancer Research Center, said, “Instead of days, weeks or even months, we had results in 20 minutes to an hour. It changed everything for us. It revolutionized things for us.”

To learn more about the OneOmics™ Suite, visit here.